CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
people who have a kidney disease called autosomal dominant polycystic kidney disease (ADPKD)....
Phase 1
MontrEal, Quebec, Canada and 9 other locations
Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors ...
Phase 3
Montreal, Quebec, Canada and 17 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Montreal, Canada and 323 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Montreal, Quebec, Canada and 295 other locations
Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...
Phase 3
Montreal, Quebec, Canada and 80 other locations
and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney...
Phase 3
Montreal, Quebec, Canada and 698 other locations
This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2...
Phase 2
Montreal, Quebec, Canada and 122 other locations
The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the cl...
Phase 3
Montreal, Quebec, Canada and 213 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Montreal, Quebec, Canada and 163 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Montreal, Quebec, Canada and 164 other locations
Clinical trials
Research sites
Resources
Legal